Table 2 Sociodemographic, clinical, and laboratory characteristics for the population in Model 2

Sex (%F)

52.97%

53.43%

51.12%

44.58%

Stratum

Low (1–2) %

3.94%

4.63%

5.11%

1.21%

Mid-level (3–4) %

91.41%

90.16%

89.65%

95.18%

High (5–6) %

4.65%

5.21%

5.24%

3.61%

Region

Bogotá %

67.92%

63.19%

65.46%

66.26%

Eastern %

6.59%

6.86%

6.36%

9.64%

Central %

9.86%

12.66%

9.85%

12.05%

Pacific %

10.56%

12.17%

13.22%

6.03%

Caribbean %

5.07%

5.12%

4.99%

6.02%

Other

0.06%

0%

0.12%

0%

Marital Status

Married %

45.44%

45.22%

42.77%

55.42%

Unmarried %

54.66%

54.88%

57.33%

44.58%

Age (IQR)

77 (71–82)

78 (73–83)

78 (73–83)

70 (58–75)

Lab tests (IQR)

TFG mL/min/1.73 m2

44.97 (35.25–52.93)

47.31 (37.01–52.68)

44.90 (34.46–52.58)

22.35 (15.52–32.31)

Triglycerides mg /dL

134.0 (100.5–182.4)

134.4 (100.1–185.05)

134.35 (101.80–184.75)

147.8 (109.85–211.45)

Hemoglobin gr/dL

13.9 (12.7–15.0)

13.9 (12.7–15.01)

13.8 (12.6–14.97)

12.6 (11.35–14.5)

Creatinine mg/dL

1.33 (1.13–1.67)

1.29 (1.09–1.55)

1.33 (1.13–1.68)

0 (0–26)

Potassium mg/dL

4.58 (4.26–4.97)

4.56 (4.26–4.93)

4.61 (4.28–4.98)

4.91 (4.43–5.35)

Cholesterol HDL mg/dL

48.4 (39.5–58.7)

48.4 (39.55–59.25)

47.5 (38.83–58.28)

45.7 (37.45–53.4)

Cholesterol LDL mg/dL

99.1 (74.1–125.1)

101.68 (76.95–126.98)

98.48 (73.95–124.27)

101.66 (74.72–131.17)

Comorbidities

Diabetes

24.42%

23.38%

24.94%

34.94%

Hypertension

80.58%

77.29%

74.31%

67.47%

Anemia

4.15%

3.77%

3.61%

2.4%

Coronary disease

19.74%

15.84%

17.95%

14.46%

Cerebrovascular disease

1.60%

-

-

1.21%

Heart failure

20.18%

17.49%

19.95%

12.05%

Rheumatoid arthritis

1.99%

-

-

-

Consumption of NSAIDs

21.80%

21.83%

19.2%

13.25%